New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib

Abbott 2025 Heart Rhythm Society (HRS) annual meeting Illinois California

Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed field ablation (PFA) therapy with the Volt™ PFA SystemThe 12-month results of the Volt CE Mark Study confirm the long-term safety and efficacy of the Volt PFA SystemThe data were presented at the 2025 Heart Rhythm Society (HRS) annual meetingView original content:https://www.prnewswire.co.uk/news-releases/new-clinical-study-data-showcase-long-term-sustained-benefits-of-abbotts-volt-pfa-system-for-patients-with-afib-302438858.html